Follow on Telegram

science/health

US Treasury Proposes Rules Targeting High-Tech Investments in Adversary Countries

The US Treasury has proposed a rule designed to restrict certain high-tech investments involving China, Russia and other countries viewed as adversaries. The proposal focuses on investment transactions valued at more than $50,000 in artificial intelligence and biotechnology. The measure would add a new layer of scrutiny to

Technology News

Investigators Study First Reported Human Infection With Shamonda Virus

Researchers are working to understand the first reported human infection with Shamonda virus. Although the case is considered exceptional, investigators are examining how the infection occurred and whether the pathogen played a role in the patient’s death. The findings could help clarify the virus’s potential transmission pathways and

Technology News

Microsoft reports gains from an AI diagnostic system on complex medical cases

Microsoft has reported that its AI diagnostic system outperformed generalist physicians on challenging cases, as the company continues its push toward what Microsoft AI CEO Mustafa Suleyman calls “medical superintelligence.” According to The Verge, the findings were published in Science and tested Microsoft’s system against human physicians using scenarios

Nvidia and UW Institute for Protein Design Release Open-Source Protein Design AI Model

Nvidia and the University of Washington Institute for Protein Design have introduced an open-source AI model designed for protein design. The release combines research expertise in computational protein design with Nvidia's AI technology, making the model available for broader use and further development in the field. Sources

Technology News

US-backed infant vaccine trial canceled after international outcry

A U.S.-backed vaccine trial involving babies has been formally canceled following an international outcry, according to Ars Technica. The trial was opposed on ethical grounds. It was canceled before police seized doses of the vaccine. Sources * Ars Technica

CAR T-cell therapy offers a potential new treatment for stiff person syndrome

A CAR T-cell therapy from Kyverna Therapeutics is being developed as a potential treatment for stiff person syndrome, a rare autoimmune disease. If authorized by the U.S. Food and Drug Administration, it would be the first approved therapy for the condition. CAR T-cell treatments work by modifying

Researchers observe virus-like particles assembling without a blueprint

Scientists at Oxford have imaged virus-like particles as they assemble, providing a step-by-step view of how complex viral structures can form without a detailed construction plan. The process appears to rely on repeated trial and error among molecular interactions. Researchers identified a crucial transition that accelerates assembly,